| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:39 UTC |
|---|
| HMDB ID | HMDB0014518 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Treprostinil |
|---|
| Description | Treprostinil is only found in individuals that have used or taken this drug. It is a synthetic analogue of prostacyclin, used to treat pulmonary hypertension. Treprostinil is marketed as Remodulin®. [Wikipedia ]The major pharmacological actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation. In addition to treprostinil's direct vasodilatory effects, it also inhibits inflammatory cytokine. As a synthetic analogue of prostacyclin, it binds to the prostacyclin receptor, which subsequently induces the aforementioned downstream effects. |
|---|
| Structure | [H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1 InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Treprostinilo | ChEBI | | Treprostinilum | ChEBI | | Remodulin | Kegg | | Orenitram | HMDB | | Trepostinil sodium | HMDB | | Treprostinil diolamine | HMDB | | Treprostinil sodium | HMDB | | UT-15 | HMDB | | UT-15C | HMDB | | ((1R,2R,3AS,9as)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate | HMDB | | Treprostinil diethanolamine | HMDB | | Treprostinil diolamin | HMDB |
|
|---|
| Chemical Formula | C23H34O5 |
|---|
| Average Molecular Weight | 390.5131 |
|---|
| Monoisotopic Molecular Weight | 390.240624198 |
|---|
| IUPAC Name | 2-{[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H,2H,3H,3aH,4H,9H,9aH-cyclopenta[b]naphthalen-5-yl]oxy}acetic acid |
|---|
| Traditional Name | treprostinil |
|---|
| CAS Registry Number | 81846-19-7 |
|---|
| SMILES | [H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1 |
|---|
| InChI Key | PAJMKGZZBBTTOY-ZFORQUDYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenoxyacetic acid derivatives. Phenoxyacetic acid derivatives are compounds containing an anisole where the methane group is linked to an acetic acid or a derivative. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Phenoxyacetic acid derivatives |
|---|
| Direct Parent | Phenoxyacetic acid derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenoxyacetate
- Tetralin
- Fatty alcohol
- Alkyl aryl ether
- Fatty acyl
- Cyclic alcohol
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Ether
- Monocarboxylic acid or derivatives
- Organic oxide
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organooxygen compound
- Aromatic homopolycyclic compound
|
|---|
| Molecular Framework | Aromatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0073 g/L | Not Available | | LogP | 4.1 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.45 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.5552 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.17 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 52.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2726.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 289.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 212.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 182.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 432.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 764.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 649.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 105.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1315.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 601.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1699.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 401.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 429.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 273.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 183.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 19.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Treprostinil,1TMS,isomer #1 | CCCCC[C@H](O)CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O)=C3C[C@H]2C[C@H]1O[Si](C)(C)C | 3206.2 | Semi standard non polar | 33892256 | | Treprostinil,1TMS,isomer #2 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O)=C3C[C@H]2C[C@H]1O)O[Si](C)(C)C | 3239.1 | Semi standard non polar | 33892256 | | Treprostinil,1TMS,isomer #3 | CCCCC[C@H](O)CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C)=C3C[C@H]2C[C@H]1O | 3189.2 | Semi standard non polar | 33892256 | | Treprostinil,2TMS,isomer #1 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O)=C3C[C@H]2C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 3219.4 | Semi standard non polar | 33892256 | | Treprostinil,2TMS,isomer #2 | CCCCC[C@H](O)CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C)=C3C[C@H]2C[C@H]1O[Si](C)(C)C | 3183.4 | Semi standard non polar | 33892256 | | Treprostinil,2TMS,isomer #3 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C)=C3C[C@H]2C[C@H]1O)O[Si](C)(C)C | 3241.5 | Semi standard non polar | 33892256 | | Treprostinil,3TMS,isomer #1 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C)=C3C[C@H]2C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 3234.8 | Semi standard non polar | 33892256 | | Treprostinil,1TBDMS,isomer #1 | CCCCC[C@H](O)CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O)=C3C[C@H]2C[C@H]1O[Si](C)(C)C(C)(C)C | 3414.2 | Semi standard non polar | 33892256 | | Treprostinil,1TBDMS,isomer #2 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O)=C3C[C@H]2C[C@H]1O)O[Si](C)(C)C(C)(C)C | 3462.0 | Semi standard non polar | 33892256 | | Treprostinil,1TBDMS,isomer #3 | CCCCC[C@H](O)CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C(C)(C)C)=C3C[C@H]2C[C@H]1O | 3423.0 | Semi standard non polar | 33892256 | | Treprostinil,2TBDMS,isomer #1 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O)=C3C[C@H]2C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3657.2 | Semi standard non polar | 33892256 | | Treprostinil,2TBDMS,isomer #2 | CCCCC[C@H](O)CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C(C)(C)C)=C3C[C@H]2C[C@H]1O[Si](C)(C)C(C)(C)C | 3645.0 | Semi standard non polar | 33892256 | | Treprostinil,2TBDMS,isomer #3 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C(C)(C)C)=C3C[C@H]2C[C@H]1O)O[Si](C)(C)C(C)(C)C | 3676.8 | Semi standard non polar | 33892256 | | Treprostinil,3TBDMS,isomer #1 | CCCCC[C@@H](CC[C@@H]1[C@H]2CC3=CC=CC(OCC(=O)O[Si](C)(C)C(C)(C)C)=C3C[C@H]2C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3870.5 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Treprostinil GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fxw-4197000000-f2c1b87e66efdc91b50e | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Treprostinil GC-MS (3 TMS) - 70eV, Positive | splash10-0076-7210190000-21ff7ee6208bb7b64a7d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Treprostinil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 10V, Positive-QTOF | splash10-05fu-0019000000-07524b6871c3cbeb6247 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 20V, Positive-QTOF | splash10-05fr-4259000000-db102057e93677a67e3f | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 40V, Positive-QTOF | splash10-0abc-9384000000-69f5a3403f3e6092f791 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 10V, Negative-QTOF | splash10-000i-0009000000-69eb101db3001417d4da | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 20V, Negative-QTOF | splash10-009i-1009000000-b4d4f7ffb8b39aec097f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 40V, Negative-QTOF | splash10-00fs-7396000000-b9875923704c71aa676a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 10V, Negative-QTOF | splash10-000i-0029000000-23c56b7cb115f5b54c17 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 20V, Negative-QTOF | splash10-0079-3089000000-21aeb3a71382c50e5572 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 40V, Negative-QTOF | splash10-00b9-4092000000-14472fa2804e67f69f32 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 10V, Positive-QTOF | splash10-0abc-0019000000-b56cc01da374c6cef594 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 20V, Positive-QTOF | splash10-0a4i-2069000000-1c37a2baaf68029ce216 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Treprostinil 40V, Positive-QTOF | splash10-0002-4092000000-e68c8ee6cce6cffc29ab | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|